AAPS PharmSci

, Volume 5, Issue 4, pp 101–111 | Cite as

A photo-crosslinked poly(vinyl alcohol) hydrogel growth factor release vehicle for wound healing applications

  • Sharon L. Bourke
  • Mohammad Al-Khalili
  • Tonye Briggs
  • Bozena B. Michniak
  • Joachim Kohn
  • Laura A. Poole-Warren


The objective of this study was to develop and evaluate a hydrogel vehicle for sustained release of growth factors for wound healing applications. Hydrogels were fabricated using ultraviolet photo-crosslinking of acrylamide-functionalized nondegradable poly(vinyl alcohol) (PVA). Protein permeability was initially assessed using trypsin inhibitor (TI), a 21 000 MW model protein drug. TI permeability was altered by changing the solids content of the gel and by adding hydrophilic PVA fillers. As the PVA content increased from 10% to 20%, protein flux decreased, with no TI permeating through 20% PVA hydrogels. Further increase in model drug release was achieved by incorporating hydrophilic PVA fillers into the hydrogel. As filler molecular weight increased, TI flux increased. The mechanism for this is most likely an alteration in protein/gel interactions and transient variations in water content. The percent protein released was also altered by varying protein loading concentration. Release studies conducted using growth factor in vehicles with hydrophilic filler showed sustained release of platelet-derived growth factor (PDGF-β,β) for up to 3 days compared with less than 24 hours in the controls. In vitro bioactivity was demonstrated by doubling of normal human dermal fibroblas numbers when exposed to growth factor-loaded vehicle compared to control. The release vehicle developed in this study uses a rapid and simple fabrication method, and protein release can be tailored by modifying solid content, incorporating biocompatible hydrophilic fillers, and varying protein loading concentration.


photo-crosslinkable hydrogel poly(vinyl alcohol) platelet-derived growth factor bioactivity sustained release 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Steed DL. Clinical evaluation of recombinant human plateletderived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. J Vasc Surg. 1995;21(1):71–78.CrossRefGoogle Scholar
  2. 2.
    Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled doubleblind study. Diabetes Care. 1998;21(5):822–827.PubMedCrossRefGoogle Scholar
  3. 3.
    Margolis DJ, Crombleholme T, Herlyn M. Clinical protocol: Phase I trial to evaluate the safety of H5.020CMV.PDGF-B for the treatment of a diabetic insensate foot ulcer. Wound Repair Regen. 2000;8(6):480–493.PubMedCrossRefGoogle Scholar
  4. 4.
    Arm DM, Tencer AF, Bain SD, Celino D. Effect of controlled release of platelet-derived growth factor from a porous hydroxyapatite implant on bone ingrowth. Biomaterials. 1996;17:703–709.PubMedCrossRefGoogle Scholar
  5. 5.
    Kim HD, Valentini RF. Human osteoblast response in vitro to platelet-derived growth factor and transforming growth factor-β delivered from controlled-release polymer rods. Biomaterials. 1997;18(17):1175–1184.PubMedCrossRefGoogle Scholar
  6. 6.
    Lee JY, Nam SH, Im SY, et al. Enhanced bone formation by controlled growth factor delivery from chitosan-based biomaterials. J Control Release. 2002;78(1–3):187–197.PubMedCrossRefGoogle Scholar
  7. 7.
    Walsh WR, Kim HD, Jong YS, Valentini RF. Controlled release of platelet-derived growth factor using ethylene vinyl acetate copolymer (EVAc) coated on stainless-steel wires. Biomaterials. 1995;16(17):1319–1325.PubMedCrossRefGoogle Scholar
  8. 8.
    Lee SJ, Park YJ, Park SN, et al. Molded porous poly(L-lactide) membranes for guided bone regeneration with enhanced effects by controlled growth factor release. J Biomed Mater Res. 2001;55(3):295–303.PubMedCrossRefGoogle Scholar
  9. 9.
    Park YJ, Ku Y, Chung CP, Lee SJ. Controlled release of platelet-derived growth factor from porous poly(L-lactide) membranes for guided tissue regeneration. J Control Release. 1998;51:201–211.PubMedCrossRefGoogle Scholar
  10. 10.
    Park YJ, Lee YM, Lee JY, Seol YJ, Chung CP, Lee SJ. Controlled release of platelet-derived growth factor-BB from chondroitin sulfate-chitosan sponge for guided bone regeneration. J Control Release. 2000;67(2–3):385–394.PubMedCrossRefGoogle Scholar
  11. 11.
    Park YJ, Lee YM, Park SN, Sheen SY, Chung CP, Lee SJ. Platelet derived growth factor releasing chitosan sponge for periodontal bone regeneration. Biomaterials. 2000;21:153–159.PubMedCrossRefGoogle Scholar
  12. 12.
    Zhou X, Zhao H. Topical treatment with growth factors for tympanic membrane perforations: progress towards clinical application. Acta Otolaryngol. 2002;122(6):586–599.PubMedCrossRefGoogle Scholar
  13. 13.
    Richardson TM, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual growth factor delivery. Nat Biotechnol. 2001;19:1029–1034.PubMedCrossRefGoogle Scholar
  14. 14.
    Peppas NA, Wright SL. Drug diffusion and binding in ionizable interpenetrating networks from poly(vinyl alcohol) and poly(acrylic acid). Eur J Pharm Biopharm. 1998;46:15–29.PubMedCrossRefGoogle Scholar
  15. 15.
    Hoffiman AS. Hydrogels for biomedical application. Adv Drug Deliv Rev. 2002;43:3–12.CrossRefGoogle Scholar
  16. 16.
    Gupta P, Vermani K, Garg S. Hydrogels: from controlled release to pH-responsive drug delivery. Drug Discov Today. 2002;7(10):569–579.PubMedCrossRefGoogle Scholar
  17. 17.
    Gander B, Gurny R, Doelker E, Peppas NA. Effect of polymeric network structure on drug release from cross-linked poly(vinyl alcohol) micromatrices. Pharm Res. 1989;6(7):578–584.PubMedCrossRefGoogle Scholar
  18. 18.
    Hennink WE, van Nostrum CF. Novel crosslinking methods to design hydrogels. Adv Drug Deliv Rev. 2002;54:13–36.PubMedCrossRefGoogle Scholar
  19. 19.
    Müller B. Photocrosslinked polymers. US patent 5 508 317. April, 16, 1996.Google Scholar
  20. 20.
    Huang X, Brazel CS. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release. 2001;73(2–3):121–136.PubMedCrossRefGoogle Scholar
  21. 21.
    Kök FN, Wilkins RM, Cain RB, Arica MY, Alaeddinoglu G, Hasirci V. Controlled release of aldicarb from lignin loaded ionotropic hydrogel microspheres. J Microencapsul. 1999;16:613–623.PubMedCrossRefGoogle Scholar
  22. 22.
    Krögel I, Bodmeier R. Development of a multifunctional matrix drug delivery system surrounded by an impermeable cylinder. J Control Release. 1999;61(1–2):43–50.PubMedCrossRefGoogle Scholar
  23. 23.
    Sako K, Sawada T, Nakashima H, Yokohama S, Sonobe T. Influence of water soluble fillers in hydroxypropylmethylcellulose matrices on in vitro and in vivo drug release. J Control Release. 2002;81(1–2):165–172.PubMedCrossRefGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2003

Authors and Affiliations

  • Sharon L. Bourke
    • 1
  • Mohammad Al-Khalili
    • 2
  • Tonye Briggs
    • 1
  • Bozena B. Michniak
    • 2
  • Joachim Kohn
    • 1
  • Laura A. Poole-Warren
    • 1
    • 3
  1. 1.New Jersey Center for Biomaterials, Department of Chemistry and Chemical BiologyRutgers UniversityPiscataway
  2. 2.New Jersey Center for BiomaterialsDrug Delivery LaboratoryNewark
  3. 3.Graduate School of Biomedical EngineeringUniversity of New South WalesSydneyAustralia

Personalised recommendations